RSS feed

Publications by Frode Vartdal

139 publications found

Original articles

Polak J, Wagnerberger JH, Torsetnes SB, Lindeman I, Høglund RAA, Vartdal F, Sollid LM, Lossius A (2023)
Single-cell transcriptomics combined with proteomics of intrathecal IgG reveal transcriptional heterogeneity of oligoclonal IgG-secreting cells in multiple sclerosis
Front Cell Neurosci, 17, 1189709
DOI 10.3389/fncel.2023.1189709, PubMed 37362001

Lindeman I, Polak J, Qiao SW, Holmøy T, Høglund RA, Vartdal F, Berg-Hansen P, Sollid LM, Lossius A (2022)
Stereotyped B-cell responses are linked to IgG constant region polymorphisms in multiple sclerosis
Eur J Immunol, 52 (4), 550-565
DOI 10.1002/eji.202149576, PubMed 35094395

Tomescu-Baciu A, Johansen JN, Holmøy T, Greiff V, Stensland M, de Souza GA, Vartdal F, Lossius A (2019)
Persistence of intrathecal oligoclonal B cells and IgG in multiple sclerosis
J Neuroimmunol, 333, 576966
DOI 10.1016/j.jneuroim.2019.576966, PubMed 31153015

Tomescu-Baciu A, Vartdal F, Holmøy T, Vedeler CA, Lossius A (2018)
G1m1 predominance of intrathecal virus-specific antibodies in multiple sclerosis
Ann Clin Transl Neurol, 5 (10), 1303-1309
DOI 10.1002/acn3.642, PubMed 30349866

Høglund RA, Polak J, Vartdal F, Holmøy T, Lossius A (2018)
B-cell composition in the blood and cerebrospinal fluid of multiple sclerosis patients treated with dimethyl fumarate
Mult Scler Relat Disord, 26, 90-95
DOI 10.1016/j.msard.2018.08.032, PubMed 30243235

Lossius A, Tomescu-Baciu A, Holmøy T, Vedeler CA, Røsjø E, Lorentzen ÅR, Casetta I, Vartdal F (2017)
Selective intrathecal enrichment of G1m1-positive B cells in multiple sclerosis
Ann Clin Transl Neurol, 4 (10), 756-761
DOI 10.1002/acn3.451, PubMed 29046884

Johansen JN, Vartdal F, Desmarais C, Tutturen AE, de Souza GA, Lossius A, Holmøy T (2015)
Intrathecal BCR transcriptome in multiple sclerosis versus other neuroinflammation: Equally diverse and compartmentalized, but more mutated, biased and overlapping with the proteome
Clin Immunol, 160 (2), 211-25
DOI 10.1016/j.clim.2015.06.001, PubMed 26055752

Lossius A, Johansen JN, Vartdal F, Robins H, Jūratė Šaltytė B, Holmøy T, Olweus J (2014)
High-throughput sequencing of TCR repertoires in multiple sclerosis reveals intrathecal enrichment of EBV-reactive CD8+ T cells
Eur J Immunol, 44 (11), 3439-52
DOI 10.1002/eji.201444662, PubMed 25103993

Lossius A, Vartdal F, Holmøy T (2011)
Vitamin D sensitive EBNA-1 specific T cells in the cerebrospinal fluid of patients with multiple sclerosis
J Neuroimmunol, 240-241, 87-96
DOI 10.1016/j.jneuroim.2011.09.011, PubMed 22018702

Skorstad G, Vandvik B, Vartdal F, Holmøy T (2009)
MS and clinically isolated syndromes: shared specificity but diverging clonal patterns of virus-specific IgG antibodies produced in vivo and by CSF B cells in vitro
Eur J Neurol, 16 (10), 1124-9
DOI 10.1111/j.1468-1331.2009.02657.x, PubMed 19469834

Hestvik AL, Skorstad G, Vartdal F, Holmøy T (2009)
Idiotope-specific CD4(+) T cells induce apoptosis of human oligodendrocytes
J Autoimmun, 32 (2), 125-32
DOI 10.1016/j.jaut.2009.01.004, PubMed 19250800

Holmøy T, Skorstad G, Hestvik AL, Alvik KM, Vartdal F (2009)
Protective and detrimental immunity: lessons from stiff person syndrome and multiple sclerosis
Acta Neurol Scand Suppl (189), 22-6
DOI 10.1111/j.1600-0404.2009.01207.x, PubMed 19566493

Skorstad G, Hestvik AL, Vartdal F, Holmøy T (2008)
Cerebrospinal fluid T cell responses against glutamic acid decarboxylase 65 in patients with stiff person syndrome
J Autoimmun, 32 (1), 24-32
DOI 10.1016/j.jaut.2008.10.002, PubMed 19027267

Skorstad G, Hestvik AL, Torjesen P, Alvik K, Vartdal F, Vandvik B, Holmøy T (2008)
GAD65 IgG autoantibodies in stiff person syndrome: clonality, avidity and persistence
Eur J Neurol, 15 (9), 973-80
DOI 10.1111/j.1468-1331.2008.02221.x, PubMed 18637036

Hestvik AL, Skorstad G, Price DA, Vartdal F, Holmoy T (2008)
Multiple sclerosis: glatiramer acetate induces anti-inflammatory T cells in the cerebrospinal fluid
Mult Scler, 14 (6), 749-58
DOI 10.1177/1352458508089411, PubMed 18611988

Lorentzen AR, Smestad C, Lie BA, Oturai AB, Akesson E, Saarela J, Myhr KM, Vartdal F, Celius EG, Sørensen PS, Hillert J, Spurkland A, Harbo HF (2008)
The SH2D2A gene and susceptibility to multiple sclerosis
J Neuroimmunol, 197 (2), 152-8
DOI 10.1016/j.jneuroim.2008.04.037, PubMed 18554728

Hestvik AL, Vartdal F, Fredriksen AB, Thompson KM, Kvale EO, Skorstad G, Bogen B, Holmoy T (2007)
T cells from multiple sclerosis patients recognize multiple epitopes on Self-IgG
Scand J Immunol, 66 (4), 393-401
DOI 10.1111/j.1365-3083.2007.01955.x, PubMed 17850583

Lorentzen AR, Celius EG, Ekstrøm PO, Wiencke K, Lie BA, Myhr KM, Ling V, Thorsby E, Vartdal F, Spurkland A, Harbo HF (2005)
Lack of association with the CD28/CTLA4/ICOS gene region among Norwegian multiple sclerosis patients
J Neuroimmunol, 166 (1-2), 197-201
DOI 10.1016/j.jneuroim.2005.06.002, PubMed 16005527

Holmøy T, Fredriksen AB, Thompson KM, Hestvik AL, Bogen B, Vartdal F (2005)
Cerebrospinal fluid T cell clones from patients with multiple sclerosis: recognition of idiotopes on monoclonal IgG secreted by autologous cerebrospinal fluid B cells
Eur J Immunol, 35 (6), 1786-94
DOI 10.1002/eji.200425417, PubMed 15864781

Holmøy T, Kvale EØ, Vartdal F (2004)
Cerebrospinal fluid CD4+ T cells from a multiple sclerosis patient cross-recognize Epstein-Barr virus and myelin basic protein
J Neurovirol, 10 (5), 278-83
DOI 10.1080/13550280490499524, PubMed 15385250

Dai KZ, Johansen FE, Kolltveit KM, Aasheim HC, Dembic Z, Vartdal F, Spurkland A (2004)
Transcriptional activation of the SH2D2A gene is dependent on a cyclic adenosine 5'-monophosphate-responsive element in the proximal SH2D2A promoter
J Immunol, 172 (10), 6144-51
DOI 10.4049/jimmunol.172.10.6144, PubMed 15128801

Harbo HF, Lie BA, Sawcer S, Celius EG, Dai KZ, Oturai A, Hillert J, Lorentzen AR, Laaksonen M, Myhr KM, Ryder LP, Fredrikson S, Nyland H, Sørensen PS, Sandberg-Wollheim M, Andersen O, Svejgaard A, Edland A, Mellgren SI, Compston A, Vartdal F, Spurkland A (2004)
Genes in the HLA class I region may contribute to the HLA class II-associated genetic susceptibility to multiple sclerosis
Tissue Antigens, 63 (3), 237-47
DOI 10.1111/j.0001-2815.2004.00173.x, PubMed 14989713

Holmøy T, Vartdal F (2004)
Cerebrospinal fluid T cells from multiple sclerosis patients recognize autologous Epstein-Barr virus-transformed B cells
J Neurovirol, 10 (1), 52-6
DOI 10.1080/13550280490261671, PubMed 14982728

Gregers TF, Fleckenstein B, Vartdal F, Roepstorff P, Bakke O, Sandlie I (2003)
MHC class II loading of high or low affinity peptides directed by Ii/peptide fusion constructs: implications for T cell activation
Int Immunol, 15 (11), 1291-9
DOI 10.1093/intimm/dxg128, PubMed 14565927

Harbo HF, Datta P, Oturai A, Ryder LP, Sawcer S, Setakis E, Akesson E, Celius EG, Modin H, Sandberg-Wollheim M, Myhr KM, Andersen O, Hillert J, Sorensen PS, Svejgaard A, Compston A, Vartdal F, Spurkland A (2003)
Two genome-wide linkage disequilibrium screens in Scandinavian multiple sclerosis patients
J Neuroimmunol, 143 (1-2), 101-6
DOI 10.1016/j.jneuroim.2003.08.021, PubMed 14575924

Etokebe GE, Opsahl M, Tveter AK, Lie BA, Thorsby E, Vartdal F, Spurkland A (2003)
Physical separation of HLA-A alleles by denaturing high-performance liquid chromatography
Tissue Antigens, 61 (6), 443-50
DOI 10.1034/j.1399-0039.2003.00058.x, PubMed 12823768

Holmøy T, Vandvik B, Vartdal F (2003)
T cells from multiple sclerosis patients recognize immunoglobulin G from cerebrospinal fluid
Mult Scler, 9 (3), 228-34
DOI 10.1191/1352458503ms906oa, PubMed 12814167

Modin H, Dai Y, Masterman T, Svejgaard A, Sørensen PS, Oturai A, Ryder LP, Spurkland A, Vartdal F, Laaksonen M, Sandberg-Wollheim M, Myhr KM, Nyland H, Hillert J (2001)
No linkage or association of the nitric oxide synthase genes to multiple sclerosis
J Neuroimmunol, 119 (1), 95-100
DOI 10.1016/s0165-5728(01)00366-6, PubMed 11525805

Dai KZ, Harbo HF, Celius EG, Oturai A, Sørensen PS, Ryder LP, Datta P, Svejgaard A, Hillert J, Fredrikson S, Sandberg-Wollheim M, Laaksonen M, Myhr KM, Nyland H, Vartdal F, Spurkland A (2001)
The T cell regulator gene SH2D2A contributes to the genetic susceptibility of multiple sclerosis
Genes Immun, 2 (5), 263-8
DOI 10.1038/sj.gene.6363774, PubMed 11528519

Vartdal F (2001)
Genetic background for immune-mediated diseases
Acta Odontol Scand, 59 (4), 212-5
DOI 10.1080/00016350152509229, PubMed 11570523

Celius EG, Harbo HF, Egeland T, Vartdal F, Vandvik B, Spurkiand A (2000)
Sex and age at diagnosis are correlated with the HLA-DR2, DQ6 haplotype in multiple sclerosis
J Neurol Sci, 178 (2), 132-5
DOI 10.1016/s0022-510x(00)00389-0, PubMed 11018705

Leivestad T, Reisaeter AV, Brekke IB, Vartdal F, Thorsby E (1999)
The role of HLA matching in renal transplantation: experience from one center
Rev Immunogenet, 1 (3), 343-50
PubMed 11256425

Harbo HF, Celius EG, Vartdal F, Spurkland A (1999)
CTLA4 promoter and exon 1 dimorphisms in multiple sclerosis
Tissue Antigens, 53 (1), 106-10
DOI 10.1034/j.1399-0039.1999.530112.x, PubMed 10082437

Fossum S, Vartdal F (1998)
[The medical prize of Anders Jahre 1998]
Ugeskr Laeger, 160 (52), 7620-1
PubMed 9889687

Reisaeter AV, Leivestad T, Vartdal F, Spurkland A, Fauchald P, Brekke IB, Thorsby E (1998)
A strong impact of matching for a limited number of HLA-DR antigens on graft survival and rejection episodes: a single-center study of first cadaveric kidneys to nonsensitized recipients
Transplantation, 66 (4), 523-8
DOI 10.1097/00007890-199808270-00018, PubMed 9734498

Straumfors A, Johansen BH, Vartdal F, Sollid LM, Thorsby E, Buus S (1998)
A peptide-binding assay for the disease-associated HLA-DQ8 molecule
Scand J Immunol, 47 (6), 561-7
DOI 10.1046/j.1365-3083.1998.00342.x, PubMed 9652824

Spurkland A, Brinchmann JE, Markussen G, Pedeutour F, Munthe E, Lea T, Vartdal F, Aasheim HC (1998)
Molecular cloning of a T cell-specific adapter protein (TSAd) containing an Src homology (SH) 2 domain and putative SH3 and phosphotyrosine binding sites
J Biol Chem, 273 (8), 4539-46
DOI 10.1074/jbc.273.8.4539, PubMed 9468509

Spurkland A, Celius EG, Knutsen I, Beiske A, Thorsby E, Vartdal F (1997)
The HLA-DQ(alpha 1*0102, beta 1*0602) heterodimer may confer susceptibility to multiple sclerosis in the absence of the HLA-DR(alpha 1*01, beta 1*1501) heterodimer
Tissue Antigens, 50 (1), 15-22
DOI 10.1111/j.1399-0039.1997.tb02828.x, PubMed 9243750

Vartdal F, Johansen BH, Friede T, Thorpe CJ, Stevanovic S, Eriksen JA, Sletten K, Rammensee HG, Thorsby E, Sollid LM (1997)
Motif for HLA-DQ2 (alpha 1*0501, beta 1*0201): anchors at P1, P4, P6, P7 and P9
HLA - GENETIC DIVERSITY OF HLA FUNCTIONAL AND MEDICAL IMPLICATION, PROCEEDINGS OF THE TWELFTH INTERNATIONAL HISTOCOMPATIBILITY WORKSHOP AND CONFERENCE (12TH IHWC), VOL II: CONFERENCE, 431-432

Sollid LM, Johansen BH, Lundin KEA, Molberg O, Scott H, Vartdal F, Thorsby E (1997)
The molecular basis of the HLA association in celiac disease - A model disease for type 1 diabetes and other HLA associated diseases
NATO ASI 3 HIGH TECH, 35, 61-69

Sollid LM, Johansen BH, Lundin KEA, Molberg O, Scott H, Sjostrom H, Thorpe CJ, Vartdal F, Thorsby E (1997)
The molecular basis of the HLA association in celiac disease: A model for other HLA-associated diseases
ALFRED BENZON SYMP S, 40, 362-377

Vartdal F, Johansen BH, Friede T, Thorpe CJ, Stevanović S, Eriksen JE, Sletten K, Thorsby E, Rammensee HG, Sollid LM (1996)
The peptide binding motif of the disease associated HLA-DQ (alpha 1* 0501, beta 1* 0201) molecule
Eur J Immunol, 26 (11), 2764-72
DOI 10.1002/eji.1830261132, PubMed 8921967

Johansen BH, Gjertsen HA, Vartdal F, Buus S, Thorsby E, Lundin KE, Sollid LM (1996)
Binding of peptides from the N-terminal region of alpha-gliadin to the celiac disease-associated HLA-DQ2 molecule assessed in biochemical and T cell assays
Clin Immunol Immunopathol, 79 (3), 288-93
DOI 10.1006/clin.1996.0081, PubMed 8635288

Johansen BH, Vartdal F, Eriksen JA, Thorsby E, Sollid LM (1996)
Identification of a putative motif for binding of peptides to HLA-DQ2
Int Immunol, 8 (2), 177-82
DOI 10.1093/intimm/8.2.177, PubMed 8671602

Johansen BH, Jensen T, Thorpe CJ, Vartdal F, Thorsby E, Sollid LM (1996)
Both alpha and beta chain polymorphisms determine the specificity of the disease-associated HLA-DQ2 molecules, with beta chain residues being most influential
Immunogenetics, 45 (2), 142-50
DOI 10.1007/s002510050182, PubMed 8952964

Leivestad T, Spurkland A, Knutsen I, Bratlie A, Vartdal F, Pfeffer P, Sødal G, Fauchald P, Thorsby E (1995)
Genomic HLA-DRB1 matching further improves clinical course after renal transplantation
Transplant Proc, 27 (1), 678-9
PubMed 7879142

Johansen BH, Gedde-Dahl T, Sollid LM, Vartdal F, Thorsby E, Gaudernack G (1994)
Binding of ras oncogene peptides to purified HLA-DQ(alpha 1*0102,beta 1*0602) and -DR(alpha,beta 1*0101) molecules
Scand J Immunol, 39 (6), 607-12
DOI 10.1111/j.1365-3083.1994.tb03420.x, PubMed 8009176

Johansen BH, Buus S, Vartdal F, Viken H, Eriksen JA, Thorsby E, Sollid LM (1994)
Binding of peptides to HLA-DQ molecules: peptide binding properties of the disease-associated HLA-DQ(alpha 1*0501, beta 1*0201) molecule
Int Immunol, 6 (3), 453-61
DOI 10.1093/intimm/6.3.453, PubMed 8186196

Spurkland A, Gedde-Dahl T, Hansen T, Vartdal F, Gaudernack G, Thorsby E (1994)
Heterogeneity of T cells specific for a particular peptide/HLA-DQ complex
Hum Immunol, 39 (1), 61-8
DOI 10.1016/0198-8859(94)90102-3, PubMed 8181964

Ploski R, Vinje O, Rønningen KS, Spurkland A, Sørskaar D, Vartdal F, Førre O (1993)
HLA class II alleles and heterogeneity of juvenile rheumatoid arthritis. DRB1*0101 may define a novel subset of the disease
Arthritis Rheum, 36 (4), 465-72
DOI 10.1002/art.1780360406, PubMed 8457222

Spurkland A, Knutsen I, Markussen G, Vartdal F, Egeland T, Thorsby E (1993)
HLA matching of unrelated bone marrow transplant pairs: direct sequencing of in vitro amplified HLA-DRB1 and -DQB1 genes using magnetic beads as solid support
Tissue Antigens, 41 (3), 155-64
DOI 10.1111/j.1399-0039.1993.tb01995.x, PubMed 8316946

Leivestad T, Sødal G, Bratlie A, Albrechtsen D, Fauchald P, Pfeffer P, Vartdal F, Thorsby E (1993)
Role of HLA matching in cadaveric renal transplantation--influence of improved serologic HLA-DR typing
Transplant Proc, 25 (1 Pt 1), 220-1
PubMed 8438277

Spurkland A, Sollid LM, Polanco I, Vartdal F, Thorsby E (1992)
HLA-DR and -DQ genotypes of celiac disease patients serologically typed to be non-DR3 or non-DR5/7
Hum Immunol, 35 (3), 188-92
DOI 10.1016/0198-8859(92)90104-u, PubMed 1293082

Brinchmann JE, Gaudernack G, Thorsby E, Vartdal F (1992)
Staphylococcal exotoxin superantigens induce human immunodeficiency virus type 1 expression in naturally infected CD4+ T cells
J Virol, 66 (10), 5924-8
DOI 10.1128/JVI.66.10.5924-5928.1992, PubMed 1356159

Spurkland A, Vartdal F (1992)
Linkage disequilibrium between DPA1 and DPB1 alleles among Norwegian Caucasoids and Japanese
Tissue Antigens, 40 (1), 1-4
DOI 10.1111/j.1399-0039.1992.tb01950.x, PubMed 1440558

Spurkland A, Rønningen KS, Leivestad T, Vartdal F, Thorsby E (1992)
HLA-DR-DQ haplotype frequencies in a Norwegian population
Transplant Proc, 24 (1), 298-9
PubMed 1539285

SPURKLAND A, RONNINGEN KS, LEIVESTAD T, VARTDAL F, THORSBY E (1992)
HLA-DR HLA-DQ HAPLOTYPE FREQUENCIES IN A NORWEGIAN POPULATION
Transplant. Proc., 24 (1), 298-299

Ronningen KS, Spurkland A, Iwe T, Sollid LM, Vartdal F, Thorsby E (1991)
Novel HLA-DR2 and -DR3 haplotypes among Norwegian Caucasians
Tissue Antigens, 37 (4), 165-7
DOI 10.1111/j.1399-0039.1991.tb01866.x, PubMed 1926125

Brinchmann JE, Albert J, Vartdal F (1991)
Few infected CD4+ T cells but a high proportion of replication-competent provirus copies in asymptomatic human immunodeficiency virus type 1 infection
J Virol, 65 (4), 2019-23
DOI 10.1128/JVI.65.4.2019-2023.1991, PubMed 1672165

Rønningen KS, Spurkland A, Iwe T, Vartdal F, Thorsby E (1991)
Distribution of HLA-DRB1, -DQA1 and -DQB1 alleles and DQA1-DQB1 genotypes among Norwegian patients with insulin-dependent diabetes mellitus
Tissue Antigens, 37 (3), 105-11
DOI 10.1111/j.1399-0039.1991.tb01854.x, PubMed 1908143

Brinchmann JE, Vartdal F, Thorsby E, Bucher A, Frøland SS, Kittelsen P, Kristoffersen J, Baklien K (1991)
[Quantification of T-lymphocyte subpopulations. Immunological marker in human immunodeficiency virus infections]
Tidsskr Nor Laegeforen, 111 (4), 440-3
PubMed 2006482

Spurkland A, Gilhus NE, Rønningen KS, Aarli JA, Vartdal F (1991)
Myasthenia gravis patients with thymus hyperplasia and myasthenia gravis patients with thymoma display different HLA associations
Tissue Antigens, 37 (2), 90-3
DOI 10.1111/j.1399-0039.1991.tb01851.x, PubMed 2057938

Brinchmann JE, Gaudernack G, Vartdal F (1991)
In vitro replication of HIV-1 in naturally infected CD4+ T cells is inhibited by rIFN alpha 2 and by a soluble factor secreted by activated CD8+ T cells, but not by rIFN beta, rIFN gamma, or recombinant tumor necrosis factor-alpha
J Acquir Immune Defic Syndr (1988), 4 (5), 480-8
PubMed 1673156

Spurkland A, Rønningen KS, Vandvik B, Thorsby E, Vartdal F (1991)
HLA-DQA1 and HLA-DQB1 genes may jointly determine susceptibility to develop multiple sclerosis
Hum Immunol, 30 (1), 69-75
DOI 10.1016/0198-8859(91)90073-i, PubMed 2001977

Rønningen KS, Spurkland A, Markussen G, Iwe T, Vartdal F, Thorsby E (1990)
Distribution of HLA class II alleles among Norwegian Caucasians
Hum Immunol, 29 (4), 275-81
DOI 10.1016/0198-8859(90)90041-m, PubMed 2286539

Spurkland A, Sollid LM, Rønningen KS, Bosnes V, Ek J, Vartdal F, Thorsby E (1990)
Susceptibility to develop celiac disease is primarily associated with HLA-DQ alleles
Hum Immunol, 29 (3), 157-65
DOI 10.1016/0198-8859(90)90111-2, PubMed 1980918

Rønningen KS, Spurkland A, Egeland T, Iwe T, Munthe E, Vartdal F, Thorsby E (1990)
Rheumatoid arthritis may be primarily associated with HLA-DR4 molecules sharing a particular sequence at residues 67-74
Tissue Antigens, 36 (5), 235-40
DOI 10.1111/j.1399-0039.1990.tb01834.x, PubMed 2095004

Brinchmann JE, Gaudernack G, Vartdal F (1990)
CD8+ T cells inhibit HIV replication in naturally infected CD4+ T cells. Evidence for a soluble inhibitor
J Immunol, 144 (8), 2961-6
PubMed 1969879

Albrechtsen D, Geiran O, Foerster A, Fauchald P, Flesland O, Lindberg H, Solheim BG, Vartdal F, Frøysaker T (1990)
Cardiac transplantation from a blood group ABO-incompatible donor: a case report
Transplant Proc, 22 (1), 143
PubMed 2309290

Leivestad T, Albrechtsen D, Bratlie A, Jakobsen A, Pfeffer P, Sødal G, Vartdal F, Flatmark A, Thorsby E (1990)
The role of HLA compatibility in renal transplantation from living donors: an analysis of 379 grafts
Transplant Proc, 22 (1), 153
PubMed 2309293

Jakobsen A, Albrechtsen D, Sødal G, Flatmark A, Fauchald P, Vartdal F (1990)
[Costs of care in uremia. How much does kidney transplantation cost?]
Tidsskr Nor Laegeforen, 110 (3), 338-41
PubMed 2309175

Mellbye OJ, Vartdal F, Pahle J, Mollnes TE (1990)
IgG and IgA subclass distribution of total immunoglobulin and rheumatoid factors in rheumatoid tissue plasma cells
Scand J Rheumatol, 19 (5), 333-40
DOI 10.3109/03009749009096788, PubMed 2218430

Brinchmann JE, Gaudernack G, Thorsby E, Jonassen TO, Vartdal F (1989)
Reliable isolation of human immunodeficiency virus from cultures of naturally infected CD4+ T cells
J Virol Methods, 25 (3), 293-300
DOI 10.1016/0166-0934(89)90056-6, PubMed 2573612

Thorsby E, Lundin KE, Rønningen KS, Sollid LM, Vartdal F (1989)
Molecular basis and functional importance of some disease-associated HLA polymorphisms
Tissue Antigens, 34 (1), 39-49
DOI 10.1111/j.1399-0039.1989.tb01716.x, PubMed 2683208

Vartdal F, Sollid LM, Vandvik B, Markussen G, Thorsby E (1989)
Patients with multiple sclerosis carry DQB1 genes which encode shared polymorphic amino acid sequences
Hum Immunol, 25 (2), 103-10
DOI 10.1016/0198-8859(89)90074-8, PubMed 2737928

Kolstad A, Hannestad K, Vandvik B, Vartdal F (1989)
Multiple sclerosis patients have a high frequency of an HLA-DQ beta epitope defined by a human-human hybridoma antibody
Tissue Antigens, 33 (5), 546-9
DOI 10.1111/j.1399-0039.1989.tb01706.x, PubMed 2477915

Brinchmann JE, Leivestad T, Vartdal F (1989)
Quantification of lymphocyte subsets based on positive immunomagnetic selection of cells directly from blood
J Immunogenet, 16 (2), 177-83
DOI 10.1111/j.1744-313x.1989.tb00460.x, PubMed 2687388

Vartdal F (1989)
HLA associations in multiple sclerosis: implications for immunopathogenesis
Res Immunol, 140 (2), 192-6; discussion 245-8
DOI 10.1016/0923-2494(89)90085-0, PubMed 2500681

BRINCHMANN JE, VARTDAL F, THORSBY E (1989)
LYMPHOCYTE-T SUBSET CHANGES IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTION
J. Acquir. Immune Defic. Syndr. Hum. Retrovirol., 2 (4), 398-403

Brinchmann JE, Vartdal F, Thorsby E (1989)
T lymphocyte subset changes in human immunodeficiency virus infection
J Acquir Immune Defic Syndr (1988), 2 (4), 398-403
PubMed 2526872

Lund A, Hellemann AL, Vartdal F (1988)
Rapid isolation of K88+ Escherichia coli by using immunomagnetic particles
J Clin Microbiol, 26 (12), 2572-5
DOI 10.1128/jcm.26.12.2572-2575.1988, PubMed 3068250

Vartdal F, Bratlie A, Thorsby E (1988)
Immunomagnetic tissue typing offers new possibilities in cadaveric transplant donor-recipient HLA matching
Transplant Proc, 20 (3), 384
PubMed 3381253

Brinchmann JE, Vartdal F, Forset KL, Thorsby E (1988)
Immunologic monitoring of rabbit antithymocyte globulin-treated transplant recipients: a comparison of serial E-RFC and immunomagnetic quantitation of CD2+ cells
Transplant Proc, 20 (3), 390-1
PubMed 3289168

UGELSTAD J, BERGE A, ELLINGSEN T, AUNE O, KILAAS L, NILSEN TN, SCHMID R, STENSTAD P, FUNDERUD S, KVALHEIM G, NUSTAD K, LEA T, VARTDAL F, DANIELSEN H (1988)
MONOSIZED MAGNETIC PARTICLES AND THEIR USE IN SELECTIVE CELL-SEPARATION
MAKROMOL CHEM-M SYMP, 17, 177-211
DOI 10.1002/masy.19880170113

LIE O, VARTDAL F, OLSAKER L, FROYSADAL E, SORENSEN A, UGELSTAD J (1988)
BOLA CLASS-II TYPING OF CELL-POPULATIONS PREPARED WITH IMMUNOMAGNETIC BEADS USING INTERSPECIES CROSSREACTIVE REAGENTS
Anim. Genet., 19 1, 15-17

Lie O, Vartdal F, Funderud S, Gaudernack G, Olsaker I, Frøysadal E, Ugelstad J, Thorsby E (1988)
Immunomagnetic isolation of cells for serological BoLA typing
Anim Genet, 19 (2), 75-86
DOI 10.1111/j.1365-2052.1988.tb00794.x, PubMed 3137848

Brinchmann JE, Vartdal F, Gaudernack G, Markussen G, Funderud S, Ugelstad J, Thorsby E (1988)
Direct immunomagnetic quantification of lymphocyte subsets in blood
Clin Exp Immunol, 71 (1), 182-6
PubMed 3349645

Halvorsen R, Gaudernack G, Leivestad T, Vartdal F, Thorsby E (1987)
Activation of resting, pure CD4+, and CD8+ cells via CD3. Requirements for second signals
Scand J Immunol, 26 (2), 197-205
DOI 10.1111/j.1365-3083.1987.tb02252.x, PubMed 2957786

Mollnes TE, Vandvik B, Lea T, Vartdal F (1987)
Intrathecal complement activation in neurological diseases evaluated by analysis of the terminal complement complex
J Neurol Sci, 78 (1), 17-28
DOI 10.1016/0022-510x(87)90074-8, PubMed 3572448

Vartdal F, Kvalheim G, Lea TE, Bosnes V, Gaudernack G, Ugelstad J, Albrechtsen D (1987)
Depletion of T lymphocytes from human bone marrow. Use of magnetic monosized polymer microspheres coated with T-lymphocyte-specific monoclonal antibodies
Transplantation, 43 (3), 366-71
DOI 10.1097/00007890-198703000-00010, PubMed 3103274

Leivestad T, Gaudernack G, Ugelstad J, Vartdal F, Thorsby E (1987)
Isolation of pure and functionally active T4 and T8 cells by positive selection with antibody-coated monosized magnetic microspheres
Transplant Proc, 19 (1 Pt 1), 265-7
PubMed 3152700

Vartdal F, Bratlie A, Gaudernack G, Funderud S, Lea T, Thorsby E (1987)
Microcytotoxic HLA typing of cells directly isolated from blood by means of antibody-coated microspheres
Transplant Proc, 19 (1 Pt 1), 655-7
PubMed 3152705

VARTDAL F, ALBRECHTSEN D, RINGDEN O, KVALHEIM G, LEA T, BOSNES V, GAUDERNACK G, BRINCHMANN J, UGELSTAD J (1987)
IMMUNOMAGNETIC TREATMENT OF BONE-MARROW ALLOGRAFTS
Bone Marrow Transplant., 2 2, 94-98

Vartdal F, Gaudernack G, Funderud S, Bratlie A, Lea T, Ugelstad J, Thorsby E (1986)
HLA class I and II typing using cells positively selected from blood by immunomagnetic isolation--a fast and reliable technique
Tissue Antigens, 28 (5), 301-12
DOI 10.1111/j.1399-0039.1986.tb00500.x, PubMed 3469787

Stavem P, Abrahamsen AF, Vartdal F, Nordhagen R, Rootwelt K (1986)
Hereditary thrombocytopenia with excessively prolonged bleeding time, corrected by infusions of platelet poor plasma
Scand J Haematol, 37 (3), 210-4
DOI 10.1111/j.1600-0609.1986.tb02299.x, PubMed 3787172

Vartdal F, Vandvik B, Lea T (1986)
Immunofluorescence staining of agarose-embedded cells. A new technique developed for immunological characterization of markers on a small number of cells
J Immunol Methods, 92 (1), 125-9
DOI 10.1016/0022-1759(86)90512-0, PubMed 3528296

Rognum TO, Vartdal F, Rodahl K, Opstad PK, Knudsen-Baas O, Kindt E, Withey WR (1986)
Physical and mental performance of soldiers on high- and low-energy diets during prolonged heavy exercise combined with sleep deprivation
Ergonomics, 29 (7), 859-67
DOI 10.1080/00140138608967198, PubMed 3743541

Lea T, Smeland E, Funderud S, Vartdal F, Davies C, Beiske K, Ugelstad J (1986)
Characterization of human mononuclear cells after positive selection with immunomagnetic particles
Scand J Immunol, 23 (4), 509-19
DOI 10.1111/j.1365-3083.1986.tb03083.x, PubMed 2422741

Walker MR, Bird P, Ulaeto DO, Vartdal F, Goodall DM, Jefferis R (1986)
Immunogenic and antigenic epitopes of immunoglobulins. XIV. Antigenic variants of IgG4 proteins revealed with monoclonal antibodies
Immunology, 57 (1), 25-8
PubMed 2417939

Lea T, Vartdal F, Davies C, Ugelstad J (1985)
Magnetic monosized polymer particles for fast and specific fractionation of human mononuclear cells
Scand J Immunol, 22 (2), 207-16
DOI 10.1111/j.1365-3083.1985.tb01873.x, PubMed 3875896

Mellbye OJ, Vartdal F, Dobloug JH (1984)
Subclasses of IgG produced in the rheumatoid synovium
Rheumatol Int, 4 Suppl, 49-52
DOI 10.1007/BF00541279, PubMed 6336226

Vartdal F, Vandvik B (1983)
Multiple sclerosis: subclasses of intrathecally synthesized IgG and measles and varicella zoster virus IgG antibodies
Clin Exp Immunol, 54 (3), 641-7
PubMed 6317243

Nordal HJ, Aarli JA, Nyland H, Vartdal F (1983)
[Immunomodulated treatment of neurologic diseases]
Tidsskr Nor Laegeforen, 103 (30), 2033-8
PubMed 6658725

Vartdal F, Vandvik B (1983)
Imprint immunofixation of electrofocused immunoglobulins
J Immunol Methods, 62 (1), 23-9
DOI 10.1016/0022-1759(83)90106-0, PubMed 6409963

Vartdal F, Vandvik B (1983)
Characterization of classes of intrathecally synthesized antibodies by imprint immunofixation of electrophoretically separated sera and cerebrospinal fluids
Acta Pathol Microbiol Immunol Scand C, 91 (1), 69-75
PubMed 6869017

Vandvik B, Nilsen RE, Vartdal F, Norrby E (1982)
Mumps meningitis: specific and non-specific antibody responses in the central nervous system
Acta Neurol Scand, 65 (5), 468-87
DOI 10.1111/j.1600-0404.1982.tb03104.x, PubMed 7051738

Vartdal F, Vandvik B (1982)
Multiple sclerosis. Electrofocused "bands" of oligoclonal CSF IgG do not carry antibody activity against measles, varicella-zoster or rotaviruses
J Neurol Sci, 54 (1), 99-107
DOI 10.1016/0022-510x(82)90222-2, PubMed 6281394

Vartdal F, Vandvik B, Norrby E (1982)
Intrathecal synthesis of virus-specific oligoclonal IgG, IgA and IgM antibodies in a case of varicella-zoster meningoencephalitis
J Neurol Sci, 57 (1), 121-32
DOI 10.1016/0022-510x(82)90116-2, PubMed 6296323

Vandvik B, Vartdal F, Norrby E (1982)
Herpes simplex virus encephalitis: intrathecal synthesis of oligoclonal virus-specific IgG, IgA and IgM antibodies
J Neurol, 228 (1), 25-38
DOI 10.1007/BF00313407, PubMed 6184456

Vartdal F, Vandvik B, Michaelsen TE, Loe K, Norrby E (1982)
Neurosyphilis: intrathecal synthesis of oligoclonal antibodies to Treponema pallidum
Ann Neurol, 11 (1), 35-40
DOI 10.1002/ana.410110107, PubMed 7036846

Togashi T, Orvell C, Vartdal F, Norrby E (1981)
Production of antibodies against measles virions by use of the mouse hybridoma technique
Arch Virol, 67 (2), 149-57
DOI 10.1007/BF01318598, PubMed 7011259

Vartdal F, Vandvik B, Norrby E (1980)
Viral and bacterial antibody responses in multiple sclerosis
Ann Neurol, 8 (3), 248-55
DOI 10.1002/ana.410080305, PubMed 6254433

Review articles

Lossius A, Johansen JN, Vartdal F, Holmøy T (2016)
High-throughput sequencing of immune repertoires in multiple sclerosis
Ann Clin Transl Neurol, 3 (4), 295-306
DOI 10.1002/acn3.295, PubMed 27081660

Lossius A, Johansen JN, Torkildsen Ø, Vartdal F, Holmøy T (2012)
Epstein-Barr virus in systemic lupus erythematosus, rheumatoid arthritis and multiple sclerosis—association and causation
Viruses, 4 (12), 3701-30
DOI 10.3390/v4123701, PubMed 23342374

Holmøy T, Vartdal F, Hestvik AL, Munthe L, Bogen B (2009)
The idiotype connection: linking infection and multiple sclerosis
Trends Immunol, 31 (2), 56-62
DOI 10.1016/j.it.2009.11.001, PubMed 19962346

Holmøy T, Harbo H, Vartdal F, Spurkland A (2009)
Genetic and molecular approaches to the immunopathogenesis of multiple sclerosis: an update
Curr Mol Med, 9 (5), 591-611
DOI 10.2174/156652409788488793, PubMed 19601809

Holmøy T, Vartdal F (2007)
The immunological basis for treatment of multiple sclerosis
Scand J Immunol, 66 (4), 374-82
DOI 10.1111/j.1365-3083.2007.01982.x, PubMed 17850581

Vartdal F, Thorsby E (1999)
[Immunologic reactions in transplantation]
Tidsskr Nor Laegeforen, 119 (21), 3167-70
PubMed 10522486

Vartdal F, Thorsby E (1999)
Transplantation immunology--the role of human leucocyte antigen in allorecognition
Curr Top Pathol, 92, 1-18
DOI 10.1007/978-3-642-59877-7_1, PubMed 9919804

Vartdal F, Rønningen KS, Sollid LM, Thorsby E (1989)
[Gene technology in immunologic research, diagnosis and treatment]
Tidsskr Nor Laegeforen, 109 (30), 3111-4
PubMed 2683198

Lea T, Vartdal F, Nustad K, Funderud S, Berge A, Ellingsen T, Schmid R, Stenstad P, Ugelstad J (1988)
Monosized, magnetic polymer particles: their use in separation of cells and subcellular components, and in the study of lymphocyte function in vitro
J Mol Recognit, 1 (1), 9-18
DOI 10.1002/jmr.300010104, PubMed 3078840

Other articles

Sollid LM, Lundin KEA, Leivestad T, Spurkland A, Vartdal F (2021)
In memoriam: Erik Thorsby (1938-2021)
Scand. J. Immunol., 94 (1), e13055
DOI 10.1111/sji.13055

Sollid LM, Lundin KEA, Leivestad T, Spurkland A, Vartdal F (2021)
Erik Thorsby (1938-2021)
Immunogenetics, 73 (3), 203-205
DOI 10.1007/s00251-021-01218-5, PubMed 33956175

Vartdal F (2018)
Congratulations on your study choice!
Tidsskr. Nor. Laegeforen., 138 (12), 1201

Vartdal F (2014)
[In accordance with the law]
Tidsskr Nor Laegeforen, 134 (3), 267
DOI 10.4045/tidsskr.14.0078, PubMed 24518453

Smeland EB, Vartdal F, Wisløff F (2010)
[Close cooperation, but not oversteering]
Tidsskr Nor Laegeforen, 130 (6), 590-1
DOI 10.4045/tidsskr.10.0153, PubMed 20348990

Smeland EB, Vartdal F, Wisløff F (2010)
[Leadership and academic competence]
Tidsskr Nor Laegeforen, 130 (6), 591
DOI 10.4045/tidsskr.10.0217, PubMed 20348994

Holmøy T, Hestvik AL, Vartdal F (2006)
Management of progressive multifocal leukoencephalopathy associated with natalizumab--possibilities and responsibility
Eur J Neurol, 13 (8), e2
DOI 10.1111/j.1468-1331.2006.01555.x, PubMed 16879280

Holmøy T, Hestvik AL, Vartdal F (2006)
Towards individualised multiple sclerosis treatment
Lancet Neurol, 5 (2), 111-2
DOI 10.1016/S1474-4422(06)70334-9, PubMed 16426986

Holmøy T, Vartdal F (2005)
Infectious causes of multiple sclerosis
Lancet Neurol, 4 (5), 268; discussion 269
DOI 10.1016/S1474-4422(05)70054-5, PubMed 15847838

Vartdal F (1998)
Erik Thorsby is 60
Tissue Antigens, 52 (1), 96-8
DOI 10.1111/j.1399-0039.1998.tb03032.x, PubMed 9714483

Johansen BH, Gedde-Dahl T, Sollid LM, Vartdal F, Thorsby E, Gaudernack G (1994)
Binding of ras oncogene peptides to purified HLA-DQ (alpha 1*0102, beta 1*0602) and -DR (alpha, beta 1*0101) molecules
Scand J Immunol, 40 (4), 468
DOI 10.1111/j.1365-3083.1994.tb03491.x, PubMed 7939420

Spurkland A, Knutsen I, Undlien DE, Vartdal F (1994)
No association of multiple sclerosis to alleles at the TAP2 locus
Hum Immunol, 39 (4), 299-301
DOI 10.1016/0198-8859(94)90273-9, PubMed 8071104

Spurkland A, Tabira T, Rønningen KS, Vandvik B, Thorsby E, Vartdal F (1991)
HLA-DRB1, -DQA1, -DQB1, -DPA1 and -DPB1 genes in Japanese multiple sclerosis patients
Tissue Antigens, 37 (4), 171-3
DOI 10.1111/j.1399-0039.1991.tb01868.x, PubMed 1926126

Sollid LM, Markussen G, Ek J, Gjerde H, Vartdal F, Thorsby E (1989)
Evidence for a primary association of celiac disease to a particular HLA-DQ alpha/beta heterodimer
J Exp Med, 169 (1), 345-50
DOI 10.1084/jem.169.1.345, PubMed 2909659

Brinchmann JE, Vartdal F, Forset KL, Thorsby E (1988)
A comparison of serial E-RFC monitoring and immunomagnetic quantitation of CD2+ cells in RATG-treated transplant recipients
Transplantation, 45 (4), 804-5
PubMed 2895968

Vartdal F, Bird P (1983)
Imprint immunofixation of IgG subclasses, using monoclonal subclass-specific antibodies
Scand J Immunol, 18 (4), 367-70
DOI 10.1111/j.1365-3083.1983.tb01809.x, PubMed 6648366

Books

Rodahl K, Tenfjord OW, Vartdal F (1977)
En orienterende arbeidsfysiologisk undersøkelse av arbeidsplassene om bord på containerskipet M/S Toyama
[Norges teknisk-naturvitenskapelige forskningsråd], [Oslo], 3 bl.,34 s.
BIBSYS 102654603

Theses

Vartdal F (1984)
Intrathecal humoral immune responses in multiple sclerosis and some infections of the central nervous system
[F. Vartdal], Oslo, 1 b. (flere pag.)
BIBSYS 842070176, ISBN 82-90522-02-9